OZO FHIR implementation guide - Local Development build (v0.2.4) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

• Narrative Content
• XML
• JSON

: Team Messaging: Clinic Response - JSON Representation

Raw json | Download

{
  "resourceType" : "Communication",
  "id" : "Communication-Team-Reply-2-Clinic-Response",
  "meta" : {
    "versionId" : "1",
    "lastUpdated" : "2025-12-04T10:30:00.000+00:00",
    "profile" : [
      🔗 "http://ozoverbindzorg.nl/fhir/StructureDefinition/OZOCommunication"
    ]
  },
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: Communication Communication-Team-Reply-2-Clinic-Response</b></p><a name=\"Communication-Team-Reply-2-Clinic-Response\"> </a><a name=\"hcCommunication-Team-Reply-2-Clinic-Response\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">version: 1; Last updated: 2025-12-04 10:30:00+0000</p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-ozo-communication.html\">OZO Communication</a></p></div><p><b>partOf</b>: <a href=\"CommunicationRequest-CommunicationRequest-Pharmacy-to-Clinic.html\">CommunicationRequest: extension = -&gt;CareTeam Apotheek de Pil - Team; status = active</a></p><p><b>inResponseTo</b>: <a href=\"Communication-Communication-Team-Reply-1-Initial-Message.html\">Communication: status = completed</a></p><p><b>status</b>: Completed</p><p><b>recipient</b>: <a href=\"CareTeam-CareTeam-Pharmacy-A.html\">Apotheek de Pil - Team</a></p><p><b>sender</b>: <a href=\"Practitioner-Practitioner-Manu-van-Weel.html\">Manu van Weel</a></p><h3>Payloads</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Content[x]</b></td></tr><tr><td style=\"display: none\">*</td><td>Dank voor het bericht. Ik heb de medicatielijst bekeken en zie geen directe interacties met de huidige medicatie. Wel adviseer ik om de INR-waarden de eerste weken extra te monitoren. Ik stuur vandaag nog een uitgebreider advies.</td></tr></table></div>"
  },
  "partOf" : [
    {
      🔗 "reference" : "CommunicationRequest/CommunicationRequest-Pharmacy-to-Clinic",
      "type" : "CommunicationRequest"
    }
  ],
  "inResponseTo" : [
    {
      🔗 "reference" : "Communication/Communication-Team-Reply-1-Initial-Message",
      "type" : "Communication"
    }
  ],
  "status" : "completed",
  "recipient" : [
    {
      🔗 "reference" : "CareTeam/CareTeam-Pharmacy-A",
      "type" : "CareTeam",
      "display" : "Apotheek de Pil - Team"
    }
  ],
  "sender" : {
    🔗 "reference" : "Practitioner/Practitioner-Manu-van-Weel",
    "type" : "Practitioner",
    "display" : "Manu van Weel"
  },
  "payload" : [
    {
      "contentString" : "Dank voor het bericht. Ik heb de medicatielijst bekeken en zie geen directe interacties met de huidige medicatie. Wel adviseer ik om de INR-waarden de eerste weken extra te monitoren. Ik stuur vandaag nog een uitgebreider advies."
    }
  ]
}